首页> 外国专利> TNF ANTAGONISTS FOR USE IN ADJUNCTIVE THERAPY TO METHOTREXATE IN THE TREATMENT OF AUTOIMMUNE DISEASES

TNF ANTAGONISTS FOR USE IN ADJUNCTIVE THERAPY TO METHOTREXATE IN THE TREATMENT OF AUTOIMMUNE DISEASES

机译：TNF拮抗剂，用于甲氨蝶呤辅助治疗自发性疾病

页面导航

摘要
著录项
相似文献

摘要

Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.

机译：公开了用于治疗和/或预防个体中TNF介导的疾病的方法。还公开了包含甲氨蝶呤和抗肿瘤坏死因子抗体的组合物。 TNF介导的疾病包括类风湿关节炎，克罗恩病以及与移植相关的急性和慢性免疫疾病。

著录项

公开/公告号PT1941904E

专利类型
公开/公告日2012-08-03

原文格式PDF
申请/专利权人 THE MATHILDA AND TERRENCE KENNEDY INSTITUTE OF RHEUMATOLOGY TRUST;
展开▼

申请/专利号PT20080005013T
发明设计人 MARC FELDMAN;RAVINDER NATH MAINI;
展开▼

申请日1997-08-01
分类号A61K39/395;A61K31/505;A61K38;A61K38/17;A61P19/02;A61P37;A61P37/06;C07K14/705;C07K16/24;
国家 PT
入库时间 2022-08-21 17:23:03

相似文献

专利
外文文献
中文文献